Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures. The
Share this article
If you liked this article share it with your friends.they will thank you later
/newsdrum-in/media/post_banners/8N4ZHuTk9D6okyRmhlx6.jpg)
1 Min read
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg){kind=logo}
